- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00753116
Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension
November 2, 2012 updated by: Medtronic Vascular
The purpose of this this study is to investigate the clinical utility of renal denervation in the treatment of ESRD patients with refractory hypertension.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55415
- Hennepin County Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Systolic blood pressure of 160 mmHg or greater
- On 3 or more antihypertensive medications
- On dialysis for more than 6 months
Exclusion Criteria:
- Renal artery abnormalities
- Known secondary hypertension attributable to a cause other than sleep apnea
- MI, angina, CVA within 6 months
- Others
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Safety - complications associated with delivery and/or use of the Ardian Catheter, adverse renal events, electrolyte disturbances, hemodynamic events.
Time Frame: Through 1 year
|
Through 1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Physiologic response to denervation (e.g., blood pressure reduction)
Time Frame: Through 1 year
|
Through 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2008
Primary Completion (Actual)
December 1, 2008
Study Completion (Actual)
December 1, 2009
Study Registration Dates
First Submitted
September 12, 2008
First Submitted That Met QC Criteria
September 15, 2008
First Posted (Estimate)
September 16, 2008
Study Record Updates
Last Update Posted (Estimate)
November 6, 2012
Last Update Submitted That Met QC Criteria
November 2, 2012
Last Verified
November 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TP-041
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Failure, Chronic
-
Centre Hospitalier Universitaire DijonTerminatedEnd-stage Chronic Kidney FailureFrance
-
Baxter Healthcare CorporationRecruitingAcute Kidney Failure | Chronic Kidney FailureChina
-
Texas A&M UniversityWithdrawnChronic Kidney FailureUnited States
-
Angiodynamics, Inc.TerminatedChronic Kidney Disease | Acute Kidney Injury | Acute Renal Failure | Renal Failure Chronic Contrast InducedUnited States
-
University of WashingtonJohns Hopkins University; National Institute of Diabetes and Digestive and... and other collaboratorsRecruitingChronic Kidney Diseases | Acute Renal Failure | Acute Renal Injury | Acute Kidney Failure | Chronic Renal Insufficiency | Kidney Failure, Acute | Renal Insufficiency, Acute | Acute Renal Insufficiency | Acute Kidney Insufficiency | Renal Failure, Acute | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney... and other conditionsUnited States
-
Hopital Jean MinjozUnknownCardiac Surgical Procedures | Preoperative KIDNEY FAILURE, CHRONIC | Postoperative KIDNEY FAILURE, ACUTEFrance
-
Pharmagest InteractiveCompletedChronic Kidney DiseasesFrance
-
Nantes University HospitalNot yet recruiting
-
Ozge AKBABAAtaturk UniversityCompletedChronic Kidney FailureTurkey
-
Chinese PLA General HospitalCompletedKidney Failure,ChronicChina
Clinical Trials on Renal Denervation with a catheter-based procedure
-
Institute of Cardiology, Warsaw, PolandCompletedHypertension | Obstructive Sleep ApneaPoland
-
Technical University of MunichCompletedHypertension | Chronic Kidney Disease | Renal Transplantation | Sympathetic ActivityGermany
-
Vivek ReddyCompletedVentricular TachycardiaUnited States, Czechia
-
Seoul St. Mary's HospitalDaiichi Sankyo Korea Co., Ltd.; Daewoong Pharmaceutical Co. LTD.UnknownHypertensionKorea, Republic of
-
Medtronic EndovascularWithdrawnResistant Hypertension | Uncontrolled Hypertension | Renal Artery AblationItaly
-
Baker Heart and Diabetes InstituteCompletedHypertension | End-stage Renal DiseaseAustralia
-
Baker Heart and Diabetes InstituteTerminated
-
University of LeipzigCompleted
-
Vivek ReddyRecruitingULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation PatientsParoxysmal Atrial Fibrillation | Persistent Atrial FibrillationUnited States
-
Vivek ReddyActive, not recruitingAtrial FibrillationUnited States